The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Parasitic Diseases Therapeutic Market Research Report 2025
Synopsis
Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.
The global Parasitic Diseases Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parasitic Diseases Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parasitic Diseases Therapeutic.
Report Scope
The Parasitic Diseases Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parasitic Diseases Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parasitic Diseases Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria
Segment by Type
Peptides Medicine
Insect Repellent
Acaricide
Other
Segment by Application
Commercial
Household
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parasitic Diseases Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.
The global Parasitic Diseases Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parasitic Diseases Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parasitic Diseases Therapeutic.
Report Scope
The Parasitic Diseases Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parasitic Diseases Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parasitic Diseases Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria
Segment by Type
Peptides Medicine
Insect Repellent
Acaricide
Other
Segment by Application
Commercial
Household
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parasitic Diseases Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Peptides Medicine
1.2.3 Insect Repellent
1.2.4 Acaricide
1.2.5 Other
1.3 Market by Application
1.3.1 Global Parasitic Diseases Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Household
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parasitic Diseases Therapeutic Market Perspective (2019-2030)
2.2 Parasitic Diseases Therapeutic Growth Trends by Region
2.2.1 Global Parasitic Diseases Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parasitic Diseases Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Parasitic Diseases Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Parasitic Diseases Therapeutic Market Dynamics
2.3.1 Parasitic Diseases Therapeutic Industry Trends
2.3.2 Parasitic Diseases Therapeutic Market Drivers
2.3.3 Parasitic Diseases Therapeutic Market Challenges
2.3.4 Parasitic Diseases Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parasitic Diseases Therapeutic Players by Revenue
3.1.1 Global Top Parasitic Diseases Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parasitic Diseases Therapeutic Revenue
3.4 Global Parasitic Diseases Therapeutic Market Concentration Ratio
3.4.1 Global Parasitic Diseases Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parasitic Diseases Therapeutic Revenue in 2023
3.5 Parasitic Diseases Therapeutic Key Players Head office and Area Served
3.6 Key Players Parasitic Diseases Therapeutic Product Solution and Service
3.7 Date of Enter into Parasitic Diseases Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parasitic Diseases Therapeutic Breakdown Data by Type
4.1 Global Parasitic Diseases Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2025-2030)
5 Parasitic Diseases Therapeutic Breakdown Data by Application
5.1 Global Parasitic Diseases Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parasitic Diseases Therapeutic Market Size (2019-2030)
6.2 North America Parasitic Diseases Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
6.4 North America Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parasitic Diseases Therapeutic Market Size (2019-2030)
7.2 Europe Parasitic Diseases Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
7.4 Europe Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Parasitic Diseases Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parasitic Diseases Therapeutic Market Size (2019-2030)
9.2 Latin America Parasitic Diseases Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Parasitic Diseases Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Parasitic Diseases Therapeutic Introduction
11.1.4 Bayer Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Introduction
11.3.4 GlaxoSmithKline Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Parasitic Diseases Therapeutic Introduction
11.4.4 Pfizer Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Sanaria
11.5.1 Sanaria Company Detail
11.5.2 Sanaria Business Overview
11.5.3 Sanaria Parasitic Diseases Therapeutic Introduction
11.5.4 Sanaria Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.5.5 Sanaria Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
